Jingjing Wang
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
High performance filtering and high-sensitivity concentration retrieval of methane in photoacoustic spectroscopy utilizing deep learning residual networks.
Journal: Photoacoustics
Published: August 14, 2024
Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects.
Journal: Antimicrobial agents and chemotherapy
Published: April 22, 2024
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes.
Journal: Clinical and translational science
Published: February 02, 2024
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects.
Journal: Antimicrobial agents and chemotherapy
Published: December 06, 2023
Corrigendum to 'Characteristics and prognostic risk factors of patients with sequence type 5 lineage-associated cryptococcosis in China' [International Journal of Infectious Diseases, 128 (2023) Pages 244-253].
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 31, 2023
Characteristics and prognostic risk factors of patients with sequence type 5 lineage-associated cryptococcosis in China.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: November 11, 2022
A Phase I Study to Evaluate the Safety and Pharmacokinetics of SHR0302 Base Ointment in Healthy Adult Volunteers.
Journal: Skin pharmacology and physiology
Published: December 02, 2021
Pharmacokinetics of Levornidazole Tablet in Healthy Chinese Subjects and Proposed Dosing Regimen Based on Pharmacokinetic/Pharmacodynamic Analysis.
Journal: Infectious diseases and therapy
Published: January 21, 2021
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects.
Journal: The Journal of infection
Published: June 27, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026